DrAIStudio

Artificial Cells, Nanomedicine, and Biotechnology call for papers

Current call-for-papers opportunities for Artificial Cells, Nanomedicine, and Biotechnology. Ranking signals: Indexed (Active), JIF 4.5. Use the official publisher page to verify scope and submission rules.

Accepting CFPs for Artificial Cells, Nanomedicine, and Biotechnology

Innovative Nanomedicines for Pulmonary Vascular Diseases Management

Deadline 2027-06-30Taylor & FrancisIndexed (Active)

Journal: Artificial Cells, Nanomedicine, and Biotechnology

Pulmonary vascular diseases (PVDs), encompassing pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension, and other disorders associated with pulmonary vascular dysfunction and remodeling, represent a heterogeneous group of clinically important cardiopulmonary diseases. Although advances in pharmacological interventions targeting vascular tone, inflammation, abnormal cellular proliferation, an…

Generate research ideas Open CFP source Submit

Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.